Prix d'achat
25,33
25,33
25,32
233.06 B
Les informations relatives aux performances passées ne constituent pas un indicateur fiable des performances futures.
The company's stock has under-performed its sector so far in 2024, while the company managed to beat EPS consensus estimates during the last quarter results. Meanwhile, Pfizer has been increasing its dividend consistently year-over-year for the last 7 years, becoming an attractive stock for dividend income-oriented investors. Additionally, Pfizer has a strong product pipeline that could potentially produce additional revenue streams in the future. Going forward, competition from generic drugs and pricing pressures remain the company's most important headwinds.
Créez un compte et procédez à une vérification rapide.
Ajoutez de l'argent à votre portefeuille par carte, virement bancaire ou crypto-monnaie.
Choisissez PFE, définissez le montant et cliquez sur acheter ou vendre - c'est tout !
Pfizer Inc.
PFE
25,325
+0.68%
FAQ